- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07798310
Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury III (PROMPT-SCI III) Trial (PROMPT-SCI III)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
GOALS: This longitudinal cohort study will investigate the clinical benefits of early acute exercise therapy after mild spinal cord injury (SCI).
Primary hypothesis: Recovering independent walking 1 year after a mild SCI is more likely with early acute exercise therapy, in comparison with a historical cohort not exposed to early acute exercise therapy. An increase in the percentage of individuals recovering independent walking in the community from 35% to 55% will be considered as a clinically meaningful increase.
Secondary hypothesis: Acute complications, neurological recovery, functional independence, quality of life and care pathway are improved with early acute exercise therapy.
METHODS: For this 5-year study, 107 participants with mild acute traumatic SCI will be recruited. Participants will perform daily 30-minute sessions of seated cycling throughout acute care, starting within 2 days of their surgery to decompress the spinal cord. The immediate response to cycling will be monitored from physiological (hemodynamic and respiratory) and electrophysiological (electromyography and H-reflex testing in lower extremities) assessments. Independent walking in the community (primary outcome) is defined by the ability to walk 100 meters outdoors without technical aids or only with leg orthosis. Secondary outcomes include all complications occurring during acute care (particularly early spasticity, pneumonia, urinary tract infection and pressure injury) and the care pathway (discharge destination and length of stay), as well as neurological recovery, functional independence and quality of life 1 year after the SCI. Outcomes will be compared to a control cohort of patients with mild SCI who did not receive exercise therapy during acute care, and the association with electrophysiological measures will be assessed.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean-Marc Mac-Thiong, MD, PhD
- Phone Number: 1+514-338-2222
- Email: jean-marc.mac-thiong@umontreal.ca
Study Contact Backup
- Name: Andreane Richard-Denis Richard-Denis, MD, MSc
- Phone Number: 1+514-338-2222
- Email: andreane.rdenis@umontreal.ca
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, h4j1c5
- Hopital Du Sacre-Coeur de Montreal
-
Contact:
- Lara Chawa
- Phone Number: 1+514-338-2222
- Email: lara.chawa.cnmtl@ssss.gouv.qc.ca
-
Principal Investigator:
- Jean-Marc Mac-Thiong, MD, PhD
-
Principal Investigator:
- Andreane Richard-Denis, MD, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adults 18 years or older with non-penetrating traumatic SCI
- SCI severity AIS grade D (motor function preserved with most key muscles able to move against gravity)
- NLI between C0 and L2; and spine surgery performed within 48 hours of SCI
Exclusion Criteria:
- intubated and mechanically ventilated
- conditions interfering with patient safety or ability to undergo cycling
- body mass index 40 kg/m2 or less (to prevent "frog leg" position during cycling)
- moderate or severe traumatic brain injury
- hemodynamic instability
- pelvic or lower extremity
- injury with weight-bearing or mobilization restrictions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Activity-based therapy
Participants will receive daily 30-minute continuous sessions of leg cycling in seated position throughout acute care, starting after surgery as soon as the patient is fit for cycling.
While the participant is seated in the armchair in the hospital room, a motorized under desk exerciser will be placed on the floor so that the feet are positioned comfortably on the pedals.
The exerciser will be positioned to ensure that maximal knee flexion during cycling will be 70 degrees.
Pedal straps are installed to secure the feet while pedaling.
Running shoes are provided to participants to prevent harmful pressure and/or friction on heels, and the risk of developing pressure injuries.
Participants will pedal at a target cadence of 40 revolutions per minute (RPM).Unless participants actively reach the target cadence of 40 RPM, motor assistance will be noted and titrated/adjusted by the research assistant until the target is reached.
|
Seated cycling using motorized under desk exerciser
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Score from Item 14 of the Spinal Cord Independence Measure ranging from a minimum of 0 to a maximum of 8 (a higher score means a better outcome)
Time Frame: 1 year
|
Ambulation in the community
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: perioperatively/periprocedurally
|
Acute complications including pneumonia, urinary tract infection, pressure injury, spasticity, etc.
|
perioperatively/periprocedurally
|
|
Presence or absence of an improvement by one American Spinal Injury Association Impairment Scale grade from baseline to 1 year
Time Frame: 1 year
|
Difference in American Spinal Injury Association Impairment Scale grade between baseline and 1 year
|
1 year
|
|
Presence or absence of neuropathic pain
Time Frame: 1 year
|
International Spinal Cord Injury Pain Basic Data Set
|
1 year
|
|
Presence or absence of improvement in motor score by 5 points from baseline to 1 year
Time Frame: 1 year
|
Difference in motor score from baseline to 1 year
|
1 year
|
|
Presence or absence of improvement in sensory scores by 10 points from baseline to 1 year
Time Frame: 1 year
|
Difference in sensory scores between baseline and 1 year
|
1 year
|
|
Presence or absence of improvement by 2 neurological levels of injury from baseline to 1 year
Time Frame: 1 year
|
Difference in neurological level of injury between baseline and 1 year
|
1 year
|
|
Total score of Spinal Cord Independence Measure ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)
Time Frame: 1 year
|
Functional independence
|
1 year
|
|
Frequence of spasms from Penn Spasm Frequency Scale ranging from a minimum of 0 to a maximum of 4 (a higher score means a worse outcome)
Time Frame: 1 year
|
Severity of spasticity
|
1 year
|
|
Physical component score from Short-form 36 ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)
Time Frame: 1 year
|
Physical component of Health-related quality of life
|
1 year
|
|
Mental component score from Short-form 36 ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)
Time Frame: 1 year
|
Mental component of Health-related quality of life
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jean-Marc Mac-Thiong, MD, PhD, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ciusss-nordmtl
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.